In committee
EARLY Act Reauthorization of 2025
This legislation continues federal support for nationwide breast and cervical cancer detection, authorizing $235.5 million each year from 2026 through 2030 for screening and diagnostic services. It expands the program to fund patient navigators who help people schedule and access care, with an added focus on reaching communities that face higher cancer rates. The bill also keeps federal breast health education initiatives for young women running through 2031 and orders an independent review to evaluate program access and barriers.
People affected—Not determinable from the text provided; the text authorizes grant programs and explicitly directs the GAO to estimate the number of eligible individuals (Sec. 202(b)(1)).
Fiscal magnitude$1.2Bprovisional · pending reviewSec. 202(a)(4)(B) authorizes $235,500,000 for each of fiscal years 2026 through 2030 for the National Breast and Cervical Cancer Early Detection Program, totaling $1,177,500,000 over five years. Sec. 102 reauthorizes breast health education programs through 2031 without specifying an amount in the operative text.
Reach30provisional · pending reviewrigor: heuristic llm
What this bill touches.
Spending vs. restraint+12Government role in coverage+15Role of government+12
Who it helps · who it burdens.
Who it helps
- Individuals at risk of breast and cervical cancerGain continued access to breast health education and outreach, as well as expanded screening, patient navigation, and diagnostic support under reauthorized and expanded federal programs (Sec. 102, Sec. 202(a)(1)).
- National Breast and Cervical Cancer Early Detection Program grant recipientsReceive authorization for $235.5 million annually through fiscal year 2030 and expanded authority to use grant funds for cancer prevention, patient navigation, and barrier-reduction activities (Sec. 202(a)(1), Sec. 202(a)(4)).
Who it burdens
- Grant-funded cancer screening and diagnostic providersMust ensure that screening and diagnostic services funded by program grants align with current evidence-based medical recommendations (Sec. 202(a)(2)).
- Government Accountability OfficeMust conduct a study and report to congressional committees by September 30, 2027, on eligible populations, service trends, and barriers to screening (Sec. 202(b)).